期刊
INTERNATIONAL JOURNAL FOR PARASITOLOGY
卷 35, 期 1, 页码 1-9出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.ijpara.2004.09.004
关键词
praziquantel; Ca2+ channels; schistosoma
类别
资金
- NIAID NIH HHS [R01 AI040522, AI 40522] Funding Source: Medline
- NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040522] Funding Source: NIH RePORTER
Praziquantel is the current drug of choice for the control of schistosomiasis. It is highly effective against all species of schistosomes and shows minimal adverse effects. Though introduced for the treatment of schistosomiasis more than 20 years ago, the mode of action of praziquantel remains to be elucidated. This review will focus on advances in defining the molecular target of praziquantel action, with particular emphasis on recent work indicating an important role for voltage-gated calcium channels. (C) 2004 Australian Society for Parasitology Inc. Published by Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据